James E. Finley
Pfizer (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Drug Transport and Resistance Mechanisms, Computational Drug Discovery Methods, Cholinesterase and Neurodegenerative Diseases, Virus-based gene therapy research
Most-Cited Works
- → Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia(2007)388 cited
- → Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing(2018)153 cited
- → Concentration-Dependent Modulation of Amyloid-β in Vivo and in Vitro Using the γ-Secretase Inhibitor, LY-450139(2006)133 cited
- → Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein Receptor(2017)109 cited
- → Pharmacodynamics and Pharmacokinetics of the γ-Secretase Inhibitor PF-3084014(2010)50 cited
- → Microphysiological systems in early stage drug development: Perspectives on current applications and future impact(2021)39 cited
- → Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: Discovery of PF-3084014(2010)31 cited
- → Growth Factors as Potential Drugs for the Sensory Epithelia of the Ear(2007)16 cited
- → P3‐380: Dendritic spine density deficits in the hippocampal CA1 region of young Tg2576 mice are ameliorated with the PDE9A inhibitor PF‐04447943(2010)15 cited
- → Development of Fluorophore-Labeled Thailanstatin Antibody-Drug Conjugates for Cellular Trafficking Studies(2017)14 cited